Tadalafil and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tadalafil (tadalafil) and Soliris (eculizumab). Common drug interactions include dehydration among females and dysphagia among males.

The phase IV clinical study analyzes what interactions people have when they take Tadalafil and Soliris. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tadalafil?

Tadalafil has active ingredients of tadalafil. It is often used in erection problems. eHealthMe is studying from 25,548 Tadalafil users. Check the latest studies of Tadalafil.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.



On Jul, 26, 2026

13 people who take Tadalafil and Soliris together, and have interactions are studied.

Tadalafil and Soliris drug interactions.

What are the common drug interactions of Tadalafil and Soliris, by gender? *:

female:

  1. Dehydration (dryness resulting from the removal of water)
  2. Mobility decreased (ability to move is reduced)
  3. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  4. Muscular weakness (muscle weakness)
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Pain
  7. Catheter site infection (infection at the site of insertion)
  8. Device occlusion
  9. Haemorrhage (bleeding)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

male:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Fatigue (feeling of tiredness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Hypoglycaemia (deficiency of glucose in the bloodstream)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Balance disorder
  8. Cellulitis (infection under the skin)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Colitis (inflammation of colon)

What are the common drug interactions of Tadalafil and Soliris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Colorectal cancer (colon cancer or bowel cancer)
  3. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  4. Hepatic steatosis (fatty liver disease)
  5. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  6. Rectal cancer (cancer of rectum)
  7. Renal cyst (kidney cyst)
  8. Stress

60+:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Fatigue (feeling of tiredness)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Labyrinthitis (inflammation of the labyrinth or inner ear)
  5. Stress
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Cellulitis (infection under the skin)
  8. Colitis (inflammation of colon)
  9. Dyslalia (inability to articulate comprehensible speech)
  10. Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)

What are the existing conditions these people have? *

  1. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 8 people, 61.54%
  2. Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 3 people, 23.08%
  3. Enlarged Prostate: 3 people, 23.08%
  4. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 2 people, 15.38%
  5. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.69%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
  7. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 1 person, 7.69%
  8. Local Anaesthesia: 1 person, 7.69%
  9. High Blood Pressure: 1 person, 7.69%
  10. Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tadalafil and Soliris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tadalafil and Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tadalafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tadalafil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soliris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tadalafil and eculizumab (the active ingredients of Tadalafil and Soliris, respectively), and Tadalafil and Soliris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: